Babak Nazer, MD
Clinical Cardiac Electrophysiology · Seattle, WANPI 1609035849
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Biosense Webster, Inc. at 33.5% of the total. 2025 is the largest year on record at $33,285, 2.4 times the $13,718 reported in 2019. Among clinical cardiac electrophysiology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $638.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$41K
- Edwards Lifesciences$25K
- Abbott$22K
- Siemens Medical Solutions USA, Inc.$20K
- Boston Scientific$8K
- Altathera Pharmaceuticals LLC$3K
- plus $4K from 8 others
Across 2 payments — averaging $29,417 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$59K
What the payments were for
- Consulting fees$59,84848%
- Speaking & faculty fees$43,64535%
- Travel & lodging$16,24013%
- Food & beverage$4,1393%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 39 | $41,442 |
| Edwards Lifesciences | 61 | $24,912 |
| Abbott | 47 | $22,181 |
| Siemens Medical Solutions USA, Inc. | 17 | $20,386 |
| Boston Scientific | 8 | $7,801 |
| Altathera Pharmaceuticals LLC | 4 | $2,880 |
| Biotronik Inc. | 4 | $2,275 |
| Medical Device Business Services, Inc. | 5 | $1,241 |
| Pfizer | 1 | $350 |
| Medtronic | 4 | $276 |
| Tarsus Pharmaceuticals, Inc. | 1 | $88 |
| Cardiva Medical, Inc. | 1 | $29 |
| Cardiofocus, Inc. | 1 | $8 |
| Stereotaxis Inc | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$27,641
- Carto 3 System$13,376
- ACUSON Origin Diagnostic Ultrasound System$13,307
- GALLANT$8,325
- ACUSON SC2000 Diagnostic Ultrasound System$6,120
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$5,245
- ENSITE$4,472
- S-ICD System Magnet$3,725
- EMBLEM$3,500
- Sotalol Hydrochloride$2,850
- ADVISOR$1,650
- EMBLEM MRI S-ICD$525
- ENSITE PRECISION$412
- Rivacor$138
- Solia$138
- Acticor$138
- Edora$138
- BioMonitor$138
- AFFERA MAPPING SYSTEM$103
- PulseSelect$101
How this compares
$123,871 in reported general payments places this provider in the 95th percentile of 68 clinical cardiac electrophysiology providers in Washington.
See all clinical cardiac electrophysiology providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 57 | $57,977 |
| XareltoRivaroxaban | 11 | $6,135 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 13 | $3,149 |
| Metoprolol Succinate | 93 | $2,012 |
| Amiodarone Hcl | 29 | $1,745 |
| SotalolSotalol Hcl | 26 | $734 |
| Flecainide Acetate | 13 | $621 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $222 |
| Carvedilol | 25 | $142 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $350 | $57,97757 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 68 clinical cardiac electrophysiology providers in Washington.
Other clinical cardiac electrophysiology in Seattle
- Gust BardySeattle$130.7M
- Toshimasa OkabeSeattle$114K
- Darryl WellsSeattle$112K
- Arun R Mahankali SridharSeattle$94K
- Jeanne PooleSeattle$81K
- David RosenthalSeattle$54K
- Eathar RazakSeattle$50K
- Uyanga BatnyamSeattle$38K
- Carlos AlvesSeattle$29K
- Robert RhoSeattle$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.